Share on StockTwits

Medtronic (NYSE:MDT) will be posting its Q115 quarterly earnings results on Tuesday, August 19th. Analysts expect Medtronic to post earnings of $0.92 per share and revenue of $4.25 billion for the quarter. Medtronic has set its FY15 guidance at $4.00-4.10 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Medtronic (NYSE:MDT) last announced its earnings results on Tuesday, May 20th. The company reported $1.12 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.12. The company had revenue of $4.60 billion for the quarter, compared to the consensus estimate of $4.58 billion. During the same quarter in the prior year, the company posted $1.10 earnings per share. The company’s quarterly revenue was up 2.4% on a year-over-year basis. On average, analysts expect Medtronic to post $4.04 EPS for the current fiscal year and $4.33 EPS for the next fiscal year.

Shares of Medtronic (NYSE:MDT) opened at 63.25 on Monday. Medtronic has a one year low of $51.22 and a one year high of $65.50. The stock’s 50-day moving average is $62.9 and its 200-day moving average is $60.37. The company has a market cap of $62.982 billion and a P/E ratio of 21.10.

A number of analysts have recently weighed in on MDT shares. Analysts at Jefferies Group upgraded shares of Medtronic from a “hold” rating to a “buy” rating in a research note on Friday, June 20th. They now have a $75.00 price target on the stock, up previously from $60.00. On a related note, analysts at Oppenheimer raised their price target on shares of Medtronic from $66.00 to $73.00 in a research note on Wednesday, June 18th. They now have an “outperform” rating on the stock. Finally, analysts at Barclays upgraded shares of Medtronic from an “equal weight” rating to an “overweight” rating in a research note on Wednesday, June 18th. They now have a $73.00 price target on the stock, up previously from $67.00. Three equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $67.63.

Medtronic, Inc (NYSE:MDT) is engaged in medical technology – alleviating pain, restoring health, and extending life for millions of people worldwide.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.